Bobby Hewlett
About Bobby Hewlett
Bobby Hewlett is a scientist at Bristol Myers Squibb with a strong background in data analysis and expertise in QC Molecular within the Cell Therapy Development and Operations department.
Company: Bristol Myers Squibb
Bobby Hewlett is currently a Scientist at Bristol Myers Squibb, where he began his latest role in February 2021. He specializes in QC Molecular within the Cell Therapy Development and Operations department. His responsibilities include various aspects of assay performance and process development support. With extensive experience in biotechnology, Hewlett brings a strong background in data analysis to his current position.
Title: Scientist at Bristol Myers Squibb
Bobby Hewlett holds the title of Scientist at Bristol Myers Squibb. His role focuses on quality control and molecular aspects within the Cell Therapy Development and Operations department. He is responsible for ensuring the performance of assays and supporting process development. Hewlett’s role is integral to maintaining high standards in biotechnology data analysis and operational processes.
Past Roles at Pharmaceutical Companies
Before his current role at Bristol Myers Squibb, Bobby Hewlett has held several key positions in the biotechnology and pharmaceuticals fields. From 2018 to 2021, he served as an Associate Scientist I at Bristol Myers Squibb in Devens, Massachusetts. Prior to that, he was a QC Analyst II at Regeneron Pharmaceuticals, Inc. from 2016 to 2018. Hewlett began his professional career at ZeptoMetrix Corporation, where he worked as a Quality Control Technician from 2014 to 2016 and briefly as an Associate Manufacturing Technician in 2014.
Education: University of Massachusetts, Amherst
Bobby Hewlett holds a Bachelor's Degree in Biochemistry and Molecular Biology from the University of Massachusetts, Amherst. He completed his studies from 2010 to 2014. This educational background laid the foundation for his expertise in the biotechnology industry, specifically in areas related to quality control, molecular processes, and assay performance.
Expertise in Assay Performance and Process Development
Bobby Hewlett is specialized in assay performance and process development support. His expertise plays a crucial role in ensuring the quality and effectiveness of biotechnological processes. At Bristol Myers Squibb, he applies his knowledge within the QC Molecular sector, contributing to the cell therapy development and operations. Hewlett’s strong background in data analysis supports his capacity to drive efficient and reliable outcomes in his field.